VER-01
Sponsors
Vertanical GmbH
Conditions
Chronic Non-specific Low Back PainFor the treatment of patients with chronic non-specific low back pain when drug treatment is indicated and previous optimised treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.HealthyLumbosacral Radiculopathy
Phase 1
Phase 2
Multicenter, double-blind, randomized, placebo-controlled, dose-response trial with the full-spectrum Cannabis Extract VER-01 in patients with chronic non-specific low back pain
CompletedCTIS2023-507358-34-00
Start: 2024-02-13End: 2025-07-31Target: 767Updated: 2025-08-15
Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain
CompletedNCT06475001
Start: 2024-06-28End: 2025-07-31Updated: 2025-08-11
Phase 3
Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain
CompletedNCT04940741
Start: 2021-07-07End: 2024-03-26Updated: 2024-04-08
Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain
CompletedNCT05610813
Start: 2023-06-08End: 2024-10-18Updated: 2024-11-25
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
Not yet recruitingNCT06956014
Start: 2026-09-01End: 2028-09-01Target: 810Updated: 2026-06-25